These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Transitional cell carcinoma recurrence in the nephrostomy tract after percutaneous resection. Oefelein MG; MacLennan G J Urol; 2003 Aug; 170(2 Pt 1):521. PubMed ID: 12853816 [No Abstract] [Full Text] [Related]
44. Concomitment spread of a renal cell carcinoma beyond the kidney and a transitional cell carcinoma beyond the bladder. Straub B; Müller M; Schrader M; Goessl C; Heicappell R; Miller K Int Urol Nephrol; 2000; 32(2):249-50. PubMed ID: 11229641 [TBL] [Abstract][Full Text] [Related]
45. Paget phenomenon of the vulva with histopathological features of high-grade urothelial carcinoma (transitional cell carcinoma). Kurashige Y; Minemura T; Nagatani T Eur J Dermatol; 2013; 23(4):556-7. PubMed ID: 23985168 [No Abstract] [Full Text] [Related]
46. Renal transplantation in a patient with multifocal transitional cell carcinoma. Dennis MJ; Ryan JJ; Bishop MC Br J Urol; 1993 Sep; 72(3):383-4. PubMed ID: 8221005 [No Abstract] [Full Text] [Related]
49. Letter re: High serum sodium predicts immunotherapy response in metastatic renal cell and urothelial carcinoma. Hong H; Qu Y Eur J Cancer; 2024 Aug; 207():114173. PubMed ID: 38901119 [No Abstract] [Full Text] [Related]
50. [Atypical scalp and adrenal metastasis of a urothelial carcinoma of the bladder]. Dossou S; James L; Afif M; Rahali L; Bazine A; Irigo J; Ogandaga E; Kebdani T; Kettani F; Benjaafar N Pan Afr Med J; 2014; 19():109. PubMed ID: 25722782 [TBL] [Abstract][Full Text] [Related]
51. Relationship between sex and immune checkpoint inhibitors in urothelial carcinoma and renal cell carcinoma. Song Y; Peng Y; Qin C World J Urol; 2023 Aug; 41(8):2301-2302. PubMed ID: 37410104 [No Abstract] [Full Text] [Related]
52. Atrophic Kidney-Like Lesion - Case Report of A Provisional Entity with Brief Review of Literature. Thirunavukkarasu B; Singh S; Sharma AP; Bal A Turk Patoloji Derg; 2022; 38(2):148-152. PubMed ID: 34514572 [TBL] [Abstract][Full Text] [Related]
53. Proliferative activity in human urologic malignancies: a preliminary study. Veronese S; Volpe R; Dal Bo V; Francini M; Carbone A; Boiocchi M Tumori; 1987 Jun; 73(3):295-9. PubMed ID: 3603726 [TBL] [Abstract][Full Text] [Related]
54. Dialysis after bilateral nephrectomy. A case report. Candela AM; Liaño F; Jiménez M; Ortuño J Nephron; 1989; 53(1):88. PubMed ID: 2779707 [No Abstract] [Full Text] [Related]
57. [Synchronous or metachronous urotheliomas of the bladder and urinary ducts. Clinical and prognostic considerations]. Pavone-Macaluso M; Contino G; Iacolino R; Ingargiola GB Arch Esp Urol; 1988 Jun; 41(5):331-3. PubMed ID: 3190270 [No Abstract] [Full Text] [Related]
58. [Ⅱ. Update on Guideline for Management of Metastatic Urothelial Carcinoma]. Hatakeyama S; Ohyama C Gan To Kagaku Ryoho; 2023 Jan; 50(1):45-49. PubMed ID: 36759986 [No Abstract] [Full Text] [Related]
59. The automatic delineation of urothelial nuclei in tissue sections. Nielsen K J Pathol; 1988 Aug; 155(4):337. PubMed ID: 3171775 [No Abstract] [Full Text] [Related]
60. Tumors of the kidneys and urinary bladder. Eble JN Mod Pathol; 2009 Jun; 22 Suppl 2():S1. PubMed ID: 19494849 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]